ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 117 filers reported holding ACLARIS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,722 | -27.5% | 3,901 | +9.7% | 0.00% | -50.0% |
| Q2 2023 | $36,876 | +60.8% | 3,556 | +25.5% | 0.00% | +100.0% |
| Q1 2023 | $22,927 | -66.7% | 2,834 | -35.2% | 0.00% | -66.7% |
| Q4 2022 | $68,891 | +20.6% | 4,374 | +20.5% | 0.00% | 0.0% |
| Q3 2022 | $57,120 | +12.7% | 3,629 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $50,661 | -1.9% | 3,629 | +21.1% | 0.00% | 0.0% |
| Q1 2022 | $51,651 | -72.0% | 2,996 | -76.4% | 0.00% | -33.3% |
| Q4 2021 | $184,600 | -19.2% | 12,696 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $228,528 | +2.5% | 12,696 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $222,942 | +149.8% | 12,696 | +5.1% | 0.00% | +50.0% |
| Q4 2018 | $89,256 | -44.4% | 12,078 | +9.2% | 0.00% | -33.3% |
| Q3 2018 | $160,533 | -99.9% | 11,056 | 0.0% | 0.00% | -25.0% |
| Q2 2018 | $220,788,000 | +68.8% | 11,056 | +48.1% | 0.00% | +100.0% |
| Q1 2018 | $130,821,000 | +70998.4% | 7,467 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $184,000 | -50.4% | 7,467 | -48.1% | 0.00% | 0.0% |
| Q3 2017 | $371,000 | -4.9% | 14,374 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $390,000 | +62.5% | 14,374 | +78.3% | 0.00% | +50.0% |
| Q1 2017 | $240,000 | +9.6% | 8,061 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $219,000 | +6.3% | 8,061 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $206,000 | – | 8,061 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,954,904 | $49,264,000 | 43.26% |
| COMMODORE CAPITAL LP | 1,028,084 | $25,908,000 | 10.32% |
| Foresite Capital Management IV, LLC | 3,399,034 | $85,656,000 | 10.26% |
| VR Adviser, LLC | 3,720,582 | $93,759,000 | 10.17% |
| Parkman Healthcare Partners LLC | 1,709,136 | $43,070,000 | 10.00% |
| Foresite Capital Management V, LLC | 1,258,243 | $31,708,000 | 9.32% |
| Stenahm Asset Managment Ltd | 283,500 | $7,144,000 | 5.04% |
| Samsara BioCapital, LLC | 1,022,612 | $25,770,000 | 4.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 336,737 | $8,486,000 | 4.63% |
| Ghost Tree Capital, LLC | 600,000 | $15,120,000 | 3.55% |